Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Performance Testing of the Modified Electrocardiogram Lead Placement

19 de julho de 2026 atualizado por: Hansu Bae

Performance Testing of the Modified Electrocardiogram Lead Placement in Patients Undergoing General Anesthesia

During general anesthesia for surgery, doctors use an electrocardiogram (ECG)-a simple heart monitor-to check for problems like poor blood flow to the heart or irregular heartbeats. Normally, ECG stickers (called electrodes) go on both shoulders and the left side of the belly, right outside the heart area, to get clear readings.

But for shoulder surgery, these spots are in the way of the operation, so doctors often place them elsewhere, like on the breastbone instead of the shoulder. This can give fuzzy or wrong results, missing key changes in the patient's heart-good or bad-during surgery.

To fix this and better watch heart health in shoulder surgery patients, this study tests different ECG sticker spots: the usual ones, the common backup (like on the breastbone), and a new idea-placing them near both temples. Researchers hope to find which setup gives the most accurate heart readings to keep patients safer.

Visão geral do estudo

Descrição detalhada

Background and Rationale Electrocardiogram (ECG) monitoring is essential during general anesthesia to assess heart rate, arrhythmias, and myocardial ischemia, alongside blood pressure. Standard Lead II, derived from limb leads placed on the torso (both clavicles below and left anterior superior iliac spine, outside the heart boundary), aligns best with the heart's electrical axis for accurate rhythm and ischemia detection. However, in shoulder surgeries like arthroscopic rotator cuff repair, surgical incisions overlap these sites, forcing electrode relocation (e.g., to the sternum instead of the shoulder). This inward shift distorts ECG signals, potentially missing normal or abnormal heart changes during surgery. To address this, modified Lead II placements are needed for reliable cardiac surveillance in shoulder surgery patients.

Study Overview This prospective, single-group interventional study evaluates the performance of two modified ECG Lead II configurations compared to the standard during general anesthesia for non-shoulder surgeries (to simulate placement feasibility). The modifications test alternative sites for the left shoulder electrode: sternum center (modified Sternum-Chest Lead II, mSC2) versus temple (modified Temple-Chest Lead II, mTC2). Left-side versions are assessed post-induction in supine position; right-side versions post-surgery. Outcomes focus on ST segment morphology similarity (visual and quantitative) to ensure modified leads maintain diagnostic accuracy without artifacts.

Methods Summary Eligible adults (19-65 years) scheduled for general anesthesia in non-shoulder sites undergo standard monitoring (ECG, NIBP, SpO2) per institutional protocols. After induction and hemodynamic stabilization, three ECG configurations are recorded simultaneously using Vital Recorder software (VitalDB, Republic of Korea) for at least 10 noise-free waves: (1) Standard Lead II; (2) Left mSC2 (sternum, right shoulder, left iliac spine); (3) Left mTC2 (left temple, right shoulder, left iliac spine). Post-surgery, right-side mSC2 and mTC2 are added. Recordings capture preoperative ST segment status (normal/abnormal). Blinded assessors (two researchers, third for ties) evaluate ST similarity visually; quantitative area differences use R/RStudio.

Statistical Considerations Sample size (n=84, 10% dropout) is calculated via McNemar test for paired comparisons, stratified by ST status (normal: 38 pairs; abnormal: 46 pairs), yielding 80% power at $\alpha=0.05$ based on pilot data. Analysis: Stratified McNemar for agreement; R for area differences.

Safety and Ethics Modifications involve brief additional recordings with no added risk beyond standard care. IRB-approved (Dongguk University Ilsan Hospital); informed consent obtained. Data anonymized (case numbers); stored securely for 3 years per regulations.

Tipo de estudo

Intervencional

Inscrição (Estimado)

84

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

  • Nome: Hansu Bae, MD
  • Número de telefone: 080-10-6326-1641
  • E-mail: hsbae81@gmail.com

Estude backup de contato

  • Nome: Dongkyu Lee, MD. Ph.D
  • Número de telefone: 080-10-6431-4217
  • E-mail: entopic@naver.com

Locais de estudo

    • Gyeonggi-do
      • Goyang-si, Gyeonggi-do, Coréia do Sul, 10326
        • Recrutamento
        • Dongguk University Il-san Hospital
        • Contato:
        • Contato:
      • Goyang-si, Gyeonggi-do, Coréia do Sul, 10326
        • Ainda não está recrutando
        • Dongguk University Ilsan Hospital
        • Contato:
          • Hansu Assistant professor, MD.
          • Número de telefone: 080-10-6326-1641
          • E-mail: hsbae81@gmail.com

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • Adult male and female patients aged 19 to 65 years scheduled for surgery under general anesthesia.
  • Patients scheduled for surgery in areas that do not affect ECG electrode placement (e.g., abdomen, head, face, lower limbs).
  • Patients with normal or abnormal ST segment changes confirmed on preoperative ECG.

Exclusion Criteria:

  • Patients who do not consent to the study.
  • Patients with implanted pacemakers.
  • Patients with a history of heart or lung surgery.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Diagnóstico
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: All Participants
All enrolled patients (n=84) undergoing general anesthesia without restrictions on ECG lead placement receive simultaneous ECG monitoring with three lead configurations: standard Lead II (baseline), left-side modified sternum-chest Lead II (mSC2), and left-side modified temple-chest Lead II (mTC2) post-induction. Right-side versions are added post-surgery. This single arm tests ST segment similarity across methods to improve intraoperative cardiac monitoring accuracy
Standard ECG Lead II monitoring: Three electrodes placed on both clavicles below and left anterior superior iliac spine (outside heart boundary). Recorded simultaneously post-induction for at least 10 noise-free waves using Vital Recorder software to establish baseline ST segment morphology during general anesthesia."
Outros nomes:
  • mSC2
  • mTC2
Modified Sternum-Chest Lead II ECG (mSC2): Electrode relocated to sternum center (replacing left shoulder), with right shoulder and left anterior superior iliac spine. Left-side version recorded post-induction; right-side post-surgery. Assesses ST segment similarity to standard for accurate ischemia detection in anesthesia.
Modified Temple-Chest Lead II ECG (mTC2): Electrode relocated near temple (replacing left shoulder), with right shoulder and left anterior superior iliac spine. Left-side version recorded post-induction; right-side post-surgery. Evaluates ST segment morphology match to standard to enhance cardiac monitoring reliability.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Percentage of participants for whom each modified Lead II configuration demonstrates superior visual similarity to the Standard Lead II
Prazo: Periprocedural
This measure evaluates and compares which of the two modified Lead II configurations (Left modified Temple-Chest Lead II [Lt-mTC2] vs. Left modified Sternum-Chest Lead II [Lt-mSC2]) aligns more accurately with the Standard Lead II. To ensure objectivity, two blinded researchers will independently compare the ECG waveform shapes and determine which modified lead shows superior visual similarity to the Standard Lead II. In cases of disagreement or tie, a third researcher will re-evaluate the waveforms for the final decision. Evaluators will be strictly blinded to the identity of the specific leads being assessed.
Periprocedural

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Percentage of participants for whom each right-side modified Lead II configuration demonstrates superior visual similarity to the Standard Lead II
Prazo: Periprocedural
This measure evaluates and compares which of the two right-side modified Lead II configurations (Right modified Temple-Chest Lead II [Rt-mTC2] vs. Right modified Sternum-Chest Lead II [Rt-mSC2]) aligns more accurately with the Standard Lead II post-surgery. Two blinded researchers will independently compare the ECG waveform shapes and determine which right-side modified lead shows superior visual similarity to the Standard Lead II. In cases of disagreement or tie, a third researcher will re-evaluate the waveforms for the final decision. Evaluators will be strictly blinded to the identity of the specific leads.
Periprocedural
Mean difference in ST segment amplitude between modified Temple-Chest Lead II (mTC2) and Standard Lead II
Prazo: Periprocedural
The quantitative difference in ST segment amplitude (measured in millimeters or millivolts) will be compared between the mTC2 configuration and the Standard Lead II. Waveform data will be processed using R and RStudio programs to calculate the absolute amplitude differences. A paired t-test will be performed to analyze the statistical agreement and determine if significant differences exist between the two leads.
Periprocedural
Mean difference in ST segment amplitude between modified Sternum-Chest Lead II (mSC2) and Standard Lead II
Prazo: Periprocedural
The quantitative difference in ST segment amplitude (measured in millimeters or millivolts) will be compared between the mSC2 configuration and the Standard Lead II. Waveform data will be processed using R and RStudio programs to calculate the absolute amplitude differences. A paired t-test will be performed to analyze the statistical agreement and determine if significant differences exist between the two leads.
Periprocedural

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

25 de fevereiro de 2026

Conclusão Primária (Estimado)

17 de dezembro de 2026

Conclusão do estudo (Estimado)

5 de novembro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

15 de novembro de 2025

Enviado pela primeira vez que atendeu aos critérios de CQ

19 de julho de 2026

Primeira postagem (Real)

22 de julho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

22 de julho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

19 de julho de 2026

Última verificação

1 de julho de 2026

Mais Informações

Termos relacionados a este estudo

Palavras-chave

Outros números de identificação do estudo

  • DUIH IRB 2025-12-018

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

No plan to share individual participant data to protect participant privacy.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever